Platinum Partner
Synbiotic Health, with deep roots in scientific research at the University of Nebraska–Lincoln, focuses on ecological innovation to develop biotic-based solutions for human and companion animal health. The company’s research team understands that successfully modulating the microbiome and improving health is best accomplished through an advanced yet pragmatic approach. Using its proprietary IVS and IVE discovery platforms, Synbiotic Health is creating the next generation of superior microorganisms designed to deliver clinical benefits for a healthy lifespan. The company offers iVS-1®, the most scientifically documented Bifidobacterium adolescentis in the global marketplace. As a foundational strain supporting physical and emotional well-being as well as longevity, B. adolescentis iVS-1® aims to enhance the quality of life for people worldwide. Synbiotic Health will soon introduce additional human-native foundational Bifidobacterium strains that provide optimized efficacy, potency, and stability.
Download the white paper on Foundations of Longevity